Confident Investing Starts With TipRanks Premium

Get 55% Off
TipRanks
Go Ultimate55% OFF

Pfizer (PFE) Drug Pipeline

Drug pipeline
Drug NameConditionStageStatusStudy NameTrial Start DateArticle
Letrozole, Fulvestrant, Pf-07220060, Cetuximab, Atirmociclib, Pf-08165784Advanced Breast Cancer, Advanced Or Metastatic Breast Cancer, Metastatic Breast Cancer (Hr+/ Her2-), Metastatic Colorectal AdenocarcinomaPhase INot Yet RecruitingA Study to Learn About the Study Medicine Called PF-08165784 in People With PIK3CA-Mutated Advanced or Metastatic Solid TumorsOct 20, 2026
Pf-08161842Alzheimer DiseasePhase INot Yet RecruitingA Study to Learn How Different Amounts of the Study Medicine Called PF-08161842 Are Tolerated and Act in the Body in Healthy and Older AdultsOct 20, 2026―
TilrekimigAsthmaPhase IIIRecruitingA Study to Learn About the Study Medicine Called Tilrekimig ( PF-07275315) in People With Severe AsthmaSep 21, 2026
Berobenatide, Pf-08653944Sleep Disorders, Apnea, Overweight And/Or ObesityPhase IIIRecruitingA Study to Learn About the Monthly Dosing Study Medicine Called Berobenatide in Adults With Breathing Problems During Sleep and Overweight or Obesity Who Use a Breathing Machine (PAP) (VESPER-OSA 1)Sep 11, 2026
RsvprefHealthy Participants, AdultPhase IIIRecruitingA Study to Learn About the Safety and Immune Responses of RSVpreF in Older AdultsSep 08, 2026
Met097, Berobenatide, Pf-08653944ObesityPhase IIINot Yet RecruitingA Study to Learn About Safety and Effects of Once-weekly Treatment With Berobenatide in Adults With Obesity Disease in Japan (VESPER-JW)Aug 26, 2026
Met097, Berobenatide, Pf-08653944ObesityPhase IIINot Yet RecruitingA Study to Learn About Safety and Effects of Once-monthly Treatment With Berobenatide in Adults With Obesity Disease in Japan (VESPER-JM)Aug 26, 2026
20 Valent Pneumococcal Conjugate Vaccine, Pg4 Multivalent Vaccine, Prevnar 20Pneumococcal DiseasePhase IIIRecruitingA Study to Assess the Safety, Tolerability, and Immunogenicity of 3 Lots of a Multivalent Pneumococcal Conjugate Vaccine Administered to AdultsAug 26, 2026
Tilrekimig And Rhuph20HealthyPhase IActive Not RecruitingA Study to Learn About the Single Dose Pharmacokinetics of Study Medicine Called Tilrekimig in Healthy Adults When Co-Mixed With rHuPH20Aug 25, 2026
Berobenatide, Pf-08653944Obesity, OverweightPhase IIINot Yet RecruitingA Study to Learn About the Study Medicine Called PF-08653944 Taken Once-Weekly Compared to Placebo in Chinese Adults With Overweight or ObesityAug 25, 2026

FAQ

What are the FDA phases for drug approval?
The FDA approval process for new drugs is divided into several phases: a. Preclinical testing b. Phase 1 – Safety and dosage c. Phase 2 – Effectiveness and side effects d. Phase 3 – Confirmation of effectiveness, monitoring of adverse reactions, and comparison with existing treatments e. Phase 4 – Post-marketing studies to track long-term safety and effectiveness
What is a clinical trial?
A clinical trial is a carefully designed study in which researchers test a drug, treatment, or medical device in people to evaluate its safety, effectiveness, and potential side effects. These trials are essential for determining whether a new treatment should be approved for widespread use.
What drugs does Pfizer Inc (MX:PFE) have in its pipeline
Pfizer MX:PFE is currently developing the following drugs: Letrozole, Fulvestrant, Pf-07220060, Cetuximab, Atirmociclib, Pf-08165784, Pf-08161842, Tilrekimig, Berobenatide, Pf-08653944, Rsvpref, Met097, Berobenatide, Pf-08653944, 20 Valent Pneumococcal Conjugate Vaccine, Pg4 Multivalent Vaccine, Prevnar 20, Tilrekimig And Rhuph20, Dupilumab, Tilrekimig, Dupixent, Pf-07275315, Tucatinib, Rsvpref Vaccine, Pf-08154225, Tilrekimig, Pf-07275315, Ritlecitinib 100 Mg, Ritlecitinib 50 Mg, Bnt162b2 Vaccine, Tdap Vaccine, Rimegepant, Pf-08653945, Rimegepant 75 Mg Odt, Atirmociclib, Pf-07220060, Ponsegromab, Midazolam, Pf-08103402, Prevnar 20, 20-Valent Pneumococcal Conjugate Vaccine, Pg4, 20-Valent Pneumococcal Conjugate Vaccine, Pg4, Prevnar 20, Odt2 Test Formulation, Odt Reference Formulation, Pf-08653944, Rabeprazole, Pf-08049820, Tafamidis, Pembrolizumab, Standard Of Care Chemotherapy, Pf-08634404, Keytruda, Oral [14C] Pf-07799544, Oral Unlabeled Pf-07799544, Iv [14C] Pf-07799544, Pf-08057418, Pf-08653944, Pf-08653945, Itraconazole, Pf-08642534, Fluorouracil, Gemcitabine, Cisplatin, Pembrolizumab, Enfortumab Vedotin, Hypofractionated Radiotherapy, Mitomycin C, Conventional Radiotherapy, Keytruda. These drug candidates are in various stages of clinical development as the company works toward FDA approval.